| Title |
In Vitro Characterization of the Anti-PD-1 Antibody Nivolumab, BMS-936558, and In Vivo Toxicology in Non-Human Primates
|
|---|---|
| Published in |
Cancer Immunology Research, September 2014
|
| DOI | 10.1158/2326-6066.cir-14-0040 |
| Pubmed ID | |
| Authors |
Changyu Wang, Kent B. Thudium, Minhua Han, Xi-Tao Wang, Haichun Huang, Diane Feingersh, Candy Garcia, Yi Wu, Michelle Kuhne, Mohan Srinivasan, Sujata Singh, Susan Wong, Neysa Garner, Heidi Leblanc, R. Todd Bunch, Diann Blanset, Mark J. Selby, Alan J. Korman |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 791 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 7 | <1% |
| Germany | 2 | <1% |
| France | 1 | <1% |
| Ireland | 1 | <1% |
| Sweden | 1 | <1% |
| Netherlands | 1 | <1% |
| Belgium | 1 | <1% |
| United Kingdom | 1 | <1% |
| Japan | 1 | <1% |
| Other | 1 | <1% |
| Unknown | 774 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 221 | 28% |
| Student > Ph. D. Student | 106 | 13% |
| Student > Bachelor | 71 | 9% |
| Other | 67 | 8% |
| Student > Master | 65 | 8% |
| Other | 97 | 12% |
| Unknown | 164 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 152 | 19% |
| Biochemistry, Genetics and Molecular Biology | 130 | 16% |
| Medicine and Dentistry | 124 | 16% |
| Immunology and Microbiology | 89 | 11% |
| Pharmacology, Toxicology and Pharmaceutical Science | 51 | 6% |
| Other | 63 | 8% |
| Unknown | 182 | 23% |
Attention Score in Context
This research output has an Altmetric Attention Score of 22. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 April 2024.
All research outputs
#1,539,345
of 23,556,846 outputs
Outputs from Cancer Immunology Research
#148
of 1,450 outputs
Outputs of similar age
#16,722
of 238,924 outputs
Outputs of similar age from Cancer Immunology Research
#1
of 29 outputs
Altmetric has tracked 23,556,846 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,450 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.3. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 238,924 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 29 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.